|
|
|
|
Ionizable lipids play a defining role in mRNA delivery, shaping how lipid nanoparticles encapsulate their payload, enter cells, release mRNA, and interact with the body. Gain insight into why advancing delivery beyond the liver will require stronger structure-function insights.
|
|
|
|
|
Given their critical function in drug products, the purity and safety of novel synthetic lipid excipients must be thoroughly demonstrated. Review the regulatory classification of LNPs, liposomes, and novel excipients, as well as the specific requirements outlined in regulatory guidance documents, to navigate emerging challenges.
|
|
|
|
|
Achieving cell-specific nucleic acid delivery requires more than identifying a promising lipid nanoparticle formulation. Discover an integrated workflow for targeted lipid nanoparticle development, covering ligand conjugation, candidate screening, and scalable manufacturing for cell-specific nucleic acid delivery.
|
|
|
|
|
Manufacturing mRNA-LNP and other complex drug products demands precision, sterility, and efficiency, especially when working with high-value APIs and small batch sizes. Explore how a modular fill-finish platform streamlines operations without compromising quality.
|
|
|
|
|
|
|
|
|
Feel the difference with a dedicated CDMO partner specializing in Lipids and Lipid-Based Drug Delivery. We’re all in to simplify the journey of advancing your therapies to patients. Discover GMP-ready, fully connected CDMO services – from lipid manufacturing through LNP formulation, manufacturing, and Fill & Finish. Choose from flexible collaboration models tailored to your path, pace, and evolving program needs. We stay focused on helping you move forward, every step of the way. Together, we’re all in.
|
|
|
